Picard Medical, Inc.
As of Oct 22, 2026, Picard Medical is in Stage 1, the basing phase, now in week 2 (since Oct 13, 2026). It closed at $7.37, 98.9% below its 52-week high and below its 200-day average, which is falling.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is PMI early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
PMI among Medical Devices130th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …130 | PMI | Stage 1 · wk 2 | 3 | +62.0% |
Picard Medical: quick answers
What stage is Picard Medical in?
As of Oct 22, 2026, Picard Medical (PMI) is in Stage 1, the basing phase. It entered Stage 1 on Oct 13, 2026 and is in week 2. What the four stages mean
Is Picard Medical in an uptrend?
Not yet. Picard Medical is in Stage 1, a base that can come before an uptrend. It trades 75.4% below its 200-day average, which is falling.
How far is Picard Medical from its 52-week high?
Picard Medical closed at $7.37 on Oct 22, 2026, 98.9% below its 52-week high of $660.00. Its 52-week low is $3.03.
How has Picard Medical performed over the past year?
As of Oct 22, 2026, Picard Medical is down 98.8% over the past year and down 91.9% so far in 2026.
Which sector and industry is Picard Medical in?
Picard Medical is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.